APPLICATION TO THE HADROTHERAPY FOR OCULAR MELANOMAS G.A. Pablo Cirrone Qualified Medical Physicist and PhD Student University of Catania and Laboratori.

Slides:



Advertisements
Similar presentations
Cirrone G. A. P. , Cuttone G. , Raffaele L. , Sabini M. G
Advertisements

Centro di AdroTerapia e Applicazioni Nucleari Avanzate Project for the development of a protontherapy facility Collaboration between INFN-Laboratori Nazionali.
A career in…. Radiation Therapy Angelina Mercuri Radiation Therapist Austin Health Radiation Oncology Centre.
Monte Carlo Based Implementation of an Energy Modulation System for Proton Therapy G.A.P. Cirrone Qualified Medical Physicist PhD Laboratori Nazionali.
Giorgio Russo National Research Council, Institute of Bioimaging and Molecular Imaging (IBFM) Fondazione Istituto San Raffaele G. Giglio di Cefalù Istituto.
F. Foppiano, M.G. Pia, M. Piergentili Medical Linac IEEE NSS, October 2004, Rome, Italy
GEANT4 simulation of an ocular proton beam & benchmark against MC codes D. R. Shipley, H. Palmans, C. Baker, A. Kacperek Monte Carlo 2005 Topical Meeting.
Ionization Chamber Array for External Beam Radiotherapy
Energy deposition and neutron background studies for a low energy proton therapy facility Roxana Rata*, Roger Barlow* * International Institute for Accelerator.
Experience, Expertise and a Commitment to Excellence™
Simulation of heavy ion therapy system using Geant4 Satoru Kameoka ※ 1, ※ 2 Takashi SASAKI ※ 1, ※ 2, Koichi MURAKAMI ※ 1, ※ 2, Tsukasa ASO ※ 2 ※ 3, Akinori.
University of Florida, Jacksonville, FL
Radiation Therapy: The Breast Cancer Patient Experience Kylie Hewitt Radiation Therapist Southern Blood & Cancer Service.
Carbon ion fragmentation study for medical applications Protons (hadrons in general) especially suitable for deep-sited tumors (brain, neck base, prostate)
ECPM 2006, Nice, France, 2-4 November DESIGN STUDIES OF THE 300AMEV SUPERCONDUCTING CYCLOTRON FOR HADRONTHERAPY Mario Maggiore Laboratori Nazionali.
Study of the fragmentation of Carbon ions for medical applications Protons (hadrons in general) especially suitable for deep-sited tumors (brain, neck.
Part 1 Introduction to Radiotherapy and External Beam Radiation Deepak Khuntia, MD Vice President, Medical Affairs Varian Medical Systems.
Geant4-INFN (Genova-LNS) Team Validation of Geant4 electromagnetic and hadronic models against proton data Validation of Geant4 electromagnetic and hadronic.
Maria Grazia Pia Systematic validation of Geant4 electromagnetic and hadronic models against proton data Systematic validation of Geant4 electromagnetic.
BIOLOGICAL EFFICIENCY OF A THERAPEUTIC PROTON BEAM: A STUDY OF HUMAN MELANOMA CELL LINE I. Petrović 1, A. Ristić-Fira 1, D. Todorović 1, L. Korićanac 1,
DOSIMETRY COMMISSIONING OF THE LNS-INFN PROTON THERAPY FACILITY THE DOSIMETRIC CHARACTERISTICS OF NARROW PROTON BEAMS USED IN EYE THERAPY HAVE BEEN DEFINED.
Radiological and Experimental Facilities Based On INR Proton LINAC Institute for nuclear research of RAS, Moscow , Russia Sergey Akulinichev, Leonid.
HIAT 2009, 9 th June, Venice 1 DESIGN STUDY OF MEDICAL CYCLOTRON SCENT300 Mario Maggiore on behalf of R&D Accelerator team Laboratori Nazionali del Sud.
Verification of the Dose Distributions with Geant4 Simulation for Proton Therapy Tsukasa Aso (Toyama College of Maritime Tech.) A.Kimura (JST CREST) S.Tanaka.
A (Quick) Survey of (Some) Medical Accelerators Dr. Todd Satogata Brookhaven National Laboratory SUNY Stony Brook PHY 684 – September 5, 2007  The NASA.
RESPONSE OF A RESISTANT HUMAN MELANOMA CELL LINE TO A THERAPEUTIC PROTON BEAM A. Ristić-Fira 1, I Petrović 1, D. Todorović 1, L. Korićanac 1, L. Valastro.
PAMELA Contact Author: CONFORM is an RCUK-funded Basic Technology Programme Charged Particle Therapy Treating cancer with protons and light ions Ken Peach,
Augen-Tumor-Therapie mit 68 MeV Protonen am Hahn-Meitner-Institut Berlin C.Rethfeldt / SF4-ATT 1. Ionenstrahllabor ISL 2. Augen-Tumor-Therapie als Anwendung.
Научно-практический центр протонной лучевой терапии и радиохирургии (Москва-Дубна) A SYSTEM FOR MEASUREMENT OF A THERAPEUTIC PROTON BEAM DOSE DISTRIBUTION.
Medical requirements for FFAG as proton beam sources Jacques BALOSSO, MD, PhD Radiation oncologiste UJF / INSERM / ETOILE FFAG 2007, April 12-17, 2007.
SOI detector Geant4-based studies to characterise the tissue-equivalence of SOI and diamond microdosimeteric detectors, under development at CMRP S. Dowdell,
1 GEANT4: Applications in Medical Physics B. Caccia Department of Technology and Health Istituto Superiore di Sanità (Italian National Institute of Health)
In vivo dosimetry Eirik Malinen Eva Stabell Bergstrand Dag Rune Olsen.
Dose distribution assessment in human eye proton therapy by Monte Carlo method 1 Department of Physics, Faculty of Science, University of Isfahan, Isfahan,
Application of a 2-D ionization chamber array for dose verification of dynamic IMRT with a micro-MLC Fujio ARAKI, PhD 1, S. TAJIRI 2, H. TOMINAGA 2, K.
Medical Accelerator F. Foppiano, M.G. Pia, M. Piergentili
Maria Grazia Pia, INFN Genova Introduction to medical physics applications Maria Grazia Pia, INFN Genova Geant4 Workshop,
Araki F. Ikegami T. and Ishidoya T.
USE OF GEANT4 CODE FOR VALIDATION OF RADIOBIOLOGICAL PARAMETERS OBTAINED AFTER PROTON AND CARBON IRRADIATIONS OF MELANOMA CELLS Ivan Petrović 1, Giuseppe.
INTRODUCTION TO HADRON THERAPY
F. Foppiano, M.G. Pia, M. Piergentili
8/Mar./041st Workshopon the Italy-Japan Collaboration on Geant4 Medical Application 1 Use-Case on treatment planning at HIMAC Koichi Murakami KEK 1 st.
If information seems to be missing, make any reasonable assumptions. 1.A target has an areal density of 2.3 g/cm 2 and a thickness of 0.8 inch. What is.
FrontierScience G.P.1 MATRIX an innovative Pixel Ionization Chamber for Online Monitoring of Hadrontherapy Treatments Giuseppe Pittà.
Implementation of a New Monte Carlo Simulation Tool for the Development of a Proton Therapy Beam Line and Verification of the related Dose Distributions.
Protontherapy at INFN-LNS C.Agodi Laboratori Nazionali del Sud - Catania LEA-COLLIGA – IPN Orsay November
The Australian Hadron Therapy and Research Facility.
Se Byeong Lee, Ph.D Chief Medical Physicist Proton Therapy Center in NCC, Korea.
M. Bruzzi, Sviluppo di sistemi di rivelazione a silicio per imaging con protoni e dosimetria Sviluppo di sistemi di rivelazione a silicio per imaging con.
Koichi MurakamiGeant4 Physics Verification and Validation (17-19/Jul./2006) 1 Results from the recent carbon test beam at HIMAC Koichi Murakami Statoru.
Adapting A Clinical Medical Accelerator For Primary Standard Dosimetry
Development of elements of 3D planning program for radiotherapy Graphical editor options  automated enclose of contour  correction of intersections 
Beam dynamics and linac optics studies for medical proton accelerators
CONFIDENTIAL MATERIAL Michele Togno - II Annual ARDENT Meeting, Milan – October, 14 th D Ionization Chambers Array for Clinical Applications.
Progress in the Application
Electron Beam Therapy.
Very High Energy Electron for Radiotherapy Studies
Diagnostics of FRIBs beam transport line
M. D. Anderson Cancer Center Houston, TX
Implementation of Object Spot Avoidance in Proton Pencil Beam Treatment on Whole Breast with Implant Metal Injector Peng Wang, PhD, DABR, Karla Leach,
F. Foppiano, S. Guatelli, B. Mascialino, M. G. Pia, M. Piergentili
Introduction to medical physics applications
APPLICATION TO THE HADROTHERAPY FOR OCULAR MELANOMAS
Geant4 physics validation: Bragg Peak
The Hadrontherapy Geant4 advanced example
Geant4 at IST Applications in Brachytherapy
Innovations in the Radiotherapy of Non–Small Cell Lung Cancer
G. A. P. Cirrone1, G. Cuttone1, F. Di Rosa1, S. Guatelli1, A
The Geant4 Hadrontherapy Advanced Example
Presentation transcript:

APPLICATION TO THE HADROTHERAPY FOR OCULAR MELANOMAS G.A. Pablo Cirrone Qualified Medical Physicist and PhD Student University of Catania and Laboratori Nazionali del Sud INFN, Italy

LNS Superconducting Cyclotron in Catania is the unique machine in in Italy and South Europe used for protontherapy

Depth doses in radiotherapy: single fields

Why clinical proton beams? penetration depth is well-defined and adjustable most energy at end-of -range protons travel in straight lines dose to normal tissue minimised no dose beyond target

MEDICAL APPLICATION OF THE CATANA FACILITY INFN - LNS Choroidal Melanoma % successfully treating with proton beams About 300 new cases for year in Italy In the world 5000 patients have been already treated with proton beams Age related subfoveal macular degenerations with subretinal neovascular membrane This is the main cause of third age blindness in EC countries It is a “social disease” for EC

0 ° respect the switching magnet 80 meter after extraction 3 m proton beam line LAYOUT OF LNS PRESENT TREATMENT ROOM

Scattering system Modulator & Range shifter Monitor chambers Ligth field Laser

Patient ready for treatment

DETECTORS USED FOR DOSE DISTRIBUTION MEASUREMENTS DEPTH DOSE DISTRIBUTION Markus Ionization chamber Silicon diode 2 mm Sensible Volume = 0.05 cm 3 LATERAL DOSE DISTRIBUTION GAF Chromic Film Thermoluminescent dosimeters Risolution 100  m for DDP and 200  m for LDP Markus Chamber layoutIrradiated GAF Chromic

‘PURE’ BRAGG PEAK EXPERIMENTAL RESULTS

MODULATED BRAGG PEAK

EXPERIMENTAL LATERAL DOSE DISTRIBUTION

Geant4 applications in prothon therapy our goals Simulation, design and realization of critical elements of a proton beam lineSimulation, design and realization of critical elements of a proton beam line  Scattering systemScattering system  Modulation systemModulation system  Collimators along the beam lineCollimators along the beam line Three dimensions dose distribution verification in water at isocenter in the treatment conditionsThree dimensions dose distribution verification in water at isocenter in the treatment conditions Comparison with experimental and treatment planning data

G. Cuttone Project Leader INFN G.A.P. Cirrone Qualified Medical Physicist and PhD student V. Salamone L. Raffaele M.G. Sabini L. Valastro P. Lojacono V. Patti Proton therapy group in Catania Qualified Medical Physicist Student for Medical Physics Qualification